阿卡波糖是一种可逆的竞争性的ɑ-葡萄糖苷酶抑制剂,属于非胰岛素依赖型糖尿病的长用药物之一。近年来国内有文献报道,本品可致肝功能损害,现概述如下:卓勤俭报道,患男,73岁,因2型糖尿病给予阿卡波糖200mg/d治疗,用药前肝功能正常,用药4周后复查肝功能示ALT 83U/L,AST 38 U/L,继续用药,8周后ALT 214U/L,AST 93U/L,予肝泰乐治疗 Acarbose is a reversible and competitive inhibitor of glucosidase and is one of the long-acting drugs for non-insulin-dependent diabetes mellitus. In recent years, there are domestic literature reports, this product can cause liver damage, are summarized as follows: Zhuo Qin Jian reported that suffering from male, 73 years old, due to type 2 diabetes acarbose 200mg / d treatment, normal liver function before treatment, medication After 4 weeks, the liver function tests showed ALT 83U / L and AST 38U / L, and continued treatment. ALT 214U / L and AST 93U / L after 8 weeks were treated with Gualutol